Latest News
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management.
This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval.
G-Therapeutics (http://gtherapeutics.com/#About) develops an implantable neuro stimulator for patients with incomplete spinal cord injury. The company’s device supports motor function recovery for better and faster rehabilitation by stimulating the spinal cord. The company was founded in 2014 as a spin-off of the Center for Neuro-Prosthetics of the renowned École Polytechnique Fédérale de Lausanne
Fried, Frank, Harris, Shriver & Jacobson has appointed Dr Christian Kleeberg as a partner in the Mergers and Acquisitions and Private Equity Practice, resident in the Firm's Frankfurt office.
Dr Kleeberg focuses his practice on private mergers and acquisitions, predominantly for private equity and other financial investors. He also represents German and international strategic investors as bidders or sellers in auction processes, and has extensive experience advising clients on the purchase and restructuring of large companies in Germany.
"The addition of Christian is a crucial step in continuing to expand our European private equity offering," says David Greenwald, chairman of
The Board of Electra Private Equity has appointed Neil Johnson as non-executive Chairman and Director of the Company with effect from 12 May 2016.
Following Johnson’s appointment, Dame Kate Barker, who has been Chairman of the Company since 5 November 2015, will resume her roles as Senior Independent Director and Chairman of the Remuneration and Nomination Committee. Roger Perkin will stand down from these roles, which he has held since Dame Kate was appointed as Chairman of the Company in November 2015.
Dame Kate Barker, Chairman, says: “This appointment follows a rigorous selection process and we are delighted to
BFF Nonwovens has secured a multi-million pound funding package from BGF (Business Growth Fund) and Lloyds Bank to pursue its growth ambitions in the UK and overseas.
Based in Bridgwater, Somerset, the company specialises in the production of high quality, bespoke technical fabrics for niche markets. Its products have a range of different end uses including filtration, packaging, acoustics and advanced wound care. BFF has invested in its manufacturing facilities to provide capacity across all of its product lines in both its Bridgwater and Bolton sites.
Under the leadership of David Lamb, Andrew Brownlow and Chris Burhop, the business has
Chemical technology company Avantium has closed a financing round of EUR20 million led by PMV, an independent investment company for Flanders, FPIM, a Belgian Federal Holding and Investment Company, and Avantium’s existing shareholders.
The funds will be used to commercialize the YXY technology for producing 100 per cent biobased packaging material PEF (polyethylenefuranoate), a next generation plastic with superior performance.
Avantium’s roll-out plan includes the construction of a ‘reference plant’, the world’s first commercial plant to produce FDCA (furandicarboxylic acid). This reference plant with a capacity of up to 50,000 metric tons per year is intended to be located in
Adams Street Partners has appointed Brijesh Jeevarathnam as a Partner and Co-Head of Global Venture Fund Investments, and member of its Primary Investment Team, effective 1 June.
Jeevarathnam joins Adams Street Partners from Commonfund, where he served as Managing Director and Co-Head of Global Venture Capital and Global Emerging Markets.
Jeevarathnam will join Kelly Meldrum, Adams Street's Head of Primary Investments, in the firm's Menlo Park office. "We have known Brijesh for many years, and have always admired his work," says Meldrum. "We are thrilled to welcome him onboard."
Prior to joining Adams Street Partners, Jeevarathnam was a member of
The Chartered Alternative Investment Analyst (CAIA) Association, a global leader in alternative investment education, has embarked on its first international branding campaign.
Titled “Mind the Gap,” CAIA’s new campaign incorporates creative advertising in the London Underground system, social media outreach to CAIA Members and prospective Members, and educational events designed to help professionals in various alternative investing disciplines better understand the changing nature of the space and the ways in which education can help them build and maintain the relevant skills, while advancing their careers.
“We chose to launch the Mind the Gap campaign in London since it is
Wynnchurch Capital and Comvest Partners announced have sold USP Holdings Inc to Forterra Building Products, a building products company based in Irving, Texas.
Headquartered in Birmingham, Alabama, US Pipe is a leading manufacturer of a broad line of ductile iron pipe products, fittings and joint restraints for water distribution and water management applications. Founded in 1899, the Company has established its market leading position with a comprehensive product portfolio supported by superior quality, capabilities, innovation and service. US Pipe serves a diverse group of customers, including distributors, contractors and municipalities.
“Wynnchurch and Comvest have been valued partners as we have
According to a new study by specialist lender, Amicus Finance, more than half (53 per cent) of small business owners expect demand for alternative finance – including forms such as property finance, crowdsourcing, invoice finance and asset finance, to increase over the next two years while just 6 per cent think it will decline.
The findings showed that small firms predict demand for alternative finance will increase by an average of 28 per cent over the next two years. This represents an increase of 2 per cent from last year’s survey where 26 per cent forecasted growth. In 2015 the
Edmond de Rothschild Asset Management has launched the Edmond de Rothschild Fund UK Synergy, available through the Edmond de Rothschild Fund UCITS umbrella domiciled in Luxembourg.
The equity fund seeks to capture upside on UK stocks that are possible bid targets and/or undergoing restructuring.
Edmond de Rothschild Fund UK Synergy invests across the whole spectrum of UK equities (circa 600 stocks). It aims to generate consistent outperformance over a complete business cycle through two complementary drivers. The fund draws upon the selection of stocks potentially targeted in takeover deals, as well as companies that may benefit from restructuring opportunities.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
